Search results
Found 460 matches for
Base Genomics announces the company's launch with $11M to commercialise epigenetic technology for early and sensitive cancer detection from a liquid biopsy.
Base Genomics announces the company's launch with $11M to commercialise epigenetic technology for early and sensitive cancer detection from a liquid biopsy.